Sartorius Stedim Biotech S.A. buy Barclays PLC
Start price
06.01.26
/
50%
€218.80
Target price
06.01.27
-
Performance (%)
-18.29%
Price
29.05.26
€178.10
Summary
This prediction is currently active. The price of Sartorius Stedim Biotech S.A. has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.29%. Dividends of €0.69 are taken into consideration when calculating the performance. This prediction currently runs until 06.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sartorius Stedim Biotech S.A. | 4.703% | 4.703% |
| iShares Core DAX® | 1.051% | 4.896% |
| iShares Nasdaq 100 | 2.414% | 11.649% |
| iShares Nikkei 225® | 4.165% | 13.991% |
| iShares S&P 500 | 0.963% | 6.365% |
Comments by Barclays_PLC for this prediction
In the thread Sartorius Stedim Biotech S.A. diskutieren
Sartorius Stedim Biotech (OTCMKTS:SDMHF) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for SDMHF provided by MarketBeat